BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38909624)

  • 1. Collateral-based selection for endovascular treatment of acute ischaemic stroke in the late window (MR CLEAN-LATE): 2-year follow-up of a phase 3, multicentre, open-label, randomised controlled trial in the Netherlands.
    Huijberts I; Pinckaers FME; Olthuis SGH; van Kuijk SMJ; Postma AA; Boogaarts HD; Roos YBWEM; Majoie CBLM; van der Lugt A; Dippel DWJ; van Zwam WH; van Oostenbrugge RJ;
    Lancet Neurol; 2024 Jun; ():. PubMed ID: 38909624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endovascular treatment versus no endovascular treatment after 6-24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial.
    Olthuis SGH; Pirson FAV; Pinckaers FME; Hinsenveld WH; Nieboer D; Ceulemans A; Knapen RRMM; Robbe MMQ; Berkhemer OA; van Walderveen MAA; Lycklama À Nijeholt GJ; Uyttenboogaart M; Schonewille WJ; van der Sluijs PM; Wolff L; van Voorst H; Postma AA; Roosendaal SD; van der Hoorn A; Emmer BJ; Krietemeijer MGM; van Doormaal PJ; Roozenbeek B; Goldhoorn RB; Staals J; de Ridder IR; van der Leij C; Coutinho JM; van der Worp HB; Lo RTH; Bokkers RPH; van Dijk EI; Boogaarts HD; Wermer MJH; van Es ACGM; van Tuijl JH; Kortman HGJ; Gons RAR; Yo LSF; Vos JA; de Laat KF; van Dijk LC; van den Wijngaard IR; Hofmeijer J; Martens JM; Brouwers PJAM; Bulut T; Remmers MJM; de Jong TEAM; den Hertog HM; van Hasselt BAAM; Rozeman AD; Elgersma OEH; van der Veen B; Sudiono DR; Lingsma HF; Roos YBWEM; Majoie CBLM; van der Lugt A; Dippel DWJ; van Zwam WH; van Oostenbrugge RJ;
    Lancet; 2023 Apr; 401(10385):1371-1380. PubMed ID: 37003289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial.
    van der Steen W; van de Graaf RA; Chalos V; Lingsma HF; van Doormaal PJ; Coutinho JM; Emmer BJ; de Ridder I; van Zwam W; van der Worp HB; van der Schaaf I; Gons RAR; Yo LSF; Boiten J; van den Wijngaard I; Hofmeijer J; Martens J; Schonewille W; Vos JA; Tuladhar AM; de Laat KF; van Hasselt B; Remmers M; Vos D; Rozeman A; Elgersma O; Uyttenboogaart M; Bokkers RPH; van Tuijl J; Boukrab I; van den Berg R; Beenen LFM; Roosendaal SD; Postma AA; Krietemeijer M; Lycklama G; Meijer FJA; Hammer S; van der Hoorn A; Yoo AJ; Gerrits D; Truijman MTB; Zinkstok S; Koudstaal PJ; Manschot S; Kerkhoff H; Nieboer D; Berkhemer O; Wolff L; van der Sluijs PM; van Voorst H; Tolhuisen M; Roos YBWEM; Majoie CBLM; Staals J; van Oostenbrugge RJ; Jenniskens SFM; van Dijk LC; den Hertog HM; van Es ACGM; van der Lugt A; Dippel DWJ; Roozenbeek B;
    Lancet; 2022 Mar; 399(10329):1059-1069. PubMed ID: 35240044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prehospital transdermal glyceryl trinitrate in patients with presumed acute stroke (MR ASAP): an ambulance-based, multicentre, randomised, open-label, blinded endpoint, phase 3 trial.
    van den Berg SA; Uniken Venema SM; Reinink H; Hofmeijer J; Schonewille WJ; Miedema I; Fransen PSS; O Pruissen DM; Raaijmakers TWM; van Dijk GW; de Leeuw FE; van Vliet JA; Kwa VIH; Kerkhoff H; van 't Net A; Boomars R; Siegers A; Lok T; Caminada K; Esteve Cuevas LM; Visser MC; Zwetsloot CP; Boomsma JMF; Schipper MH; van Eijkelenburg RPJ; Berkhemer OA; Nieboer D; Lingsma HF; Emmer BJ; van Oostenbrugge RJ; van der Lugt A; Roos YBWEM; Majoie CBLM; Dippel DWJ; Nederkoorn PJ; van der Worp HB;
    Lancet Neurol; 2022 Nov; 21(11):971-981. PubMed ID: 36058230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of baseline Alberta Stroke Program Early CT Score on safety and efficacy of intra-arterial treatment: a subgroup analysis of a randomised phase 3 trial (MR CLEAN).
    Yoo AJ; Berkhemer OA; Fransen PSS; van den Berg LA; Beumer D; Lingsma HF; Schonewille WJ; Sprengers MES; van den Berg R; van Walderveen MAA; Beenen LFM; Wermer MJH; Nijeholt GJLÀ; Boiten J; Jenniskens SFM; Bot JCJ; Boers AMM; Marquering HA; Roos YBWEM; van Oostenbrugge RJ; Dippel DWJ; van der Lugt A; van Zwam WH; Majoie CBLM;
    Lancet Neurol; 2016 Jun; 15(7):685-694. PubMed ID: 27302238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endovascular treatment for acute ischaemic stroke in routine clinical practice: prospective, observational cohort study (MR CLEAN Registry).
    Jansen IGH; Mulder MJHL; Goldhoorn RB;
    BMJ; 2018 Mar; 360():k949. PubMed ID: 29523557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR CLEAN-LATE, a multicenter randomized clinical trial of endovascular treatment of acute ischemic stroke in The Netherlands for late arrivals: study protocol for a randomized controlled trial.
    Pirson FAVA; Hinsenveld WH; Goldhoorn RB; Staals J; de Ridder IR; van Zwam WH; van Walderveen MAA; Lycklama À Nijeholt GJ; Uyttenboogaart M; Schonewille WJ; van der Lugt A; Dippel DWJ; Roos YBWEM; Majoie CBLM; van Oostenbrugge RJ;
    Trials; 2021 Feb; 22(1):160. PubMed ID: 33627168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials.
    Goyal M; Menon BK; van Zwam WH; Dippel DW; Mitchell PJ; Demchuk AM; Dávalos A; Majoie CB; van der Lugt A; de Miquel MA; Donnan GA; Roos YB; Bonafe A; Jahan R; Diener HC; van den Berg LA; Levy EI; Berkhemer OA; Pereira VM; Rempel J; Millán M; Davis SM; Roy D; Thornton J; Román LS; Ribó M; Beumer D; Stouch B; Brown S; Campbell BC; van Oostenbrugge RJ; Saver JL; Hill MD; Jovin TG;
    Lancet; 2016 Apr; 387(10029):1723-31. PubMed ID: 26898852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.
    Hill MD; Goyal M; Menon BK; Nogueira RG; McTaggart RA; Demchuk AM; Poppe AY; Buck BH; Field TS; Dowlatshahi D; van Adel BA; Swartz RH; Shah RA; Sauvageau E; Zerna C; Ospel JM; Joshi M; Almekhlafi MA; Ryckborst KJ; Lowerison MW; Heard K; Garman D; Haussen D; Cutting SM; Coutts SB; Roy D; Rempel JL; Rohr AC; Iancu D; Sahlas DJ; Yu AYX; Devlin TG; Hanel RA; Puetz V; Silver FL; Campbell BCV; Chapot R; Teitelbaum J; Mandzia JL; Kleinig TJ; Turkel-Parrella D; Heck D; Kelly ME; Bharatha A; Bang OY; Jadhav A; Gupta R; Frei DF; Tarpley JW; McDougall CG; Holmin S; Rha JH; Puri AS; Camden MC; Thomalla G; Choe H; Phillips SJ; Schindler JL; Thornton J; Nagel S; Heo JH; Sohn SI; Psychogios MN; Budzik RF; Starkman S; Martin CO; Burns PA; Murphy S; Lopez GA; English J; Tymianski M;
    Lancet; 2020 Mar; 395(10227):878-887. PubMed ID: 32087818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4·5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial.
    Gusev EI; Martynov MY; Nikonov AA; Shamalov NA; Semenov MP; Gerasimets EA; Yarovaya EB; Semenov AM; Archakov AI; Markin SS;
    Lancet Neurol; 2021 Sep; 20(9):721-728. PubMed ID: 34418399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trial.
    Mitchell PJ; Yan B; Churilov L; Dowling RJ; Bush SJ; Bivard A; Huo XC; Wang G; Zhang SY; Ton MD; Cordato DJ; Kleinig TJ; Ma H; Chandra RV; Brown H; Campbell BCV; Cheung AK; Steinfort B; Scroop R; Redmond K; Miteff F; Liu Y; Duc DP; Rice H; Parsons MW; Wu TY; Nguyen HT; Donnan GA; Miao ZR; Davis SM;
    Lancet; 2022 Jul; 400(10346):116-125. PubMed ID: 35810757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial.
    Liu X; Dai Q; Ye R; Zi W; Liu Y; Wang H; Zhu W; Ma M; Yin Q; Li M; Fan X; Sun W; Han Y; Lv Q; Liu R; Yang D; Shi Z; Zheng D; Deng X; Wan Y; Wang Z; Geng Y; Chen X; Zhou Z; Liao G; Jin P; Liu Y; Liu X; Zhang M; Zhou F; Shi H; Zhang Y; Guo F; Yin C; Niu G; Zhang M; Cai X; Zhu Q; Chen Z; Liang Y; Li B; Lin M; Wang W; Xu H; Fu X; Liu W; Tian X; Gong Z; Shi H; Wang C; Lv P; Tao Z; Zhu L; Yang S; Hu W; Jiang P; Liebeskind DS; Pereira VM; Leung T; Yan B; Davis S; Xu G; Nogueira RG;
    Lancet Neurol; 2020 Feb; 19(2):115-122. PubMed ID: 31831388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial.
    Yang P; Song L; Zhang Y; Zhang X; Chen X; Li Y; Sun L; Wan Y; Billot L; Li Q; Ren X; Shen H; Zhang L; Li Z; Xing P; Zhang Y; Zhang P; Hua W; Shen F; Zhou Y; Tian B; Chen W; Han H; Zhang L; Xu C; Li T; Peng Y; Yue X; Chen S; Wen C; Wan S; Yin C; Wei M; Shu H; Nan G; Liu S; Liu W; Cai Y; Sui Y; Chen M; Zhou Y; Zuo Q; Dai D; Zhao R; Li Q; Huang Q; Xu Y; Deng B; Wu T; Lu J; Wang X; Parsons MW; Butcher K; Campbell B; Robinson TG; Goyal M; Dippel D; Roos Y; Majoie C; Wang L; Wang Y; Liu J; Anderson CS;
    Lancet; 2022 Nov; 400(10363):1585-1596. PubMed ID: 36341753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of endovascular treatment after 6-24 h in ischaemic stroke patients with collateral flow on CT-angiography: A model-based economic evaluation of the MR CLEAN-LATE trial.
    Pinckaers FM; Evers SM; Olthuis SG; Boogaarts HD; Postma AA; van Oostenbrugge RJ; van Zwam WH; Grutters JP
    Eur Stroke J; 2024 Jun; 9(2):348-355. PubMed ID: 38153049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of GABA
    Chabriat H; Bassetti CL; Marx U; Audoli-Inthavong ML; Sors A; Lambert E; Wattez M; Hermann DM;
    Lancet Neurol; 2020 Mar; 19(3):226-233. PubMed ID: 32085836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial.
    Bendszus M; Fiehler J; Subtil F; Bonekamp S; Aamodt AH; Fuentes B; Gizewski ER; Hill MD; Krajina A; Pierot L; Simonsen CZ; Zeleňák K; Blauenfeldt RA; Cheng B; Denis A; Deutschmann H; Dorn F; Flottmann F; Gellißen S; Gerber JC; Goyal M; Haring J; Herweh C; Hopf-Jensen S; Hua VT; Jensen M; Kastrup A; Keil CF; Klepanec A; Kurča E; Mikkelsen R; Möhlenbruch M; Müller-Hülsbeck S; Münnich N; Pagano P; Papanagiotou P; Petzold GC; Pham M; Puetz V; Raupach J; Reimann G; Ringleb PA; Schell M; Schlemm E; Schönenberger S; Tennøe B; Ulfert C; Vališ K; Vítková E; Vollherbst DF; Wick W; Thomalla G;
    Lancet; 2023 Nov; 402(10414):1753-1763. PubMed ID: 37837989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endovascular treatment in anterior circulation stroke beyond 6.5 hours after onset or time last seen well: results from the MR CLEAN Registry.
    Dekker L; Venema E; Pirson FAV; Majoie CBLM; Emmer BJ; Jansen IGH; Mulder MJHL; Lemmens R; Goldhoorn RB; Wermer MJH; Boiten J; Lycklama À Nijeholt GJ; Roos YBWEM; van Es ACGM; Lingsma HF; Dippel DWJ; van Zwam WH; van Oostenbrugge RJ; van den Wijngaard IR;
    Stroke Vasc Neurol; 2021 Dec; 6(4):572-580. PubMed ID: 33827915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data.
    Román LS; Menon BK; Blasco J; Hernández-Pérez M; Dávalos A; Majoie CBLM; Campbell BCV; Guillemin F; Lingsma H; Anxionnat R; Epstein J; Saver JL; Marquering H; Wong JH; Lopes D; Reimann G; Desal H; Dippel DWJ; Coutts S; du Mesnil de Rochemont R; Yavagal D; Ferre JC; Roos YBWEM; Liebeskind DS; Lenthall R; Molina C; Al Ajlan FS; Reddy V; Dowlatshahi D; Sourour NA; Oppenheim C; Mitha AP; Davis SM; Weimar C; van Oostenbrugge RJ; Cobo E; Kleinig TJ; Donnan GA; van der Lugt A; Demchuk AM; Berkhemer OA; Boers AMM; Ford GA; Muir KW; Brown BS; Jovin T; van Zwam WH; Mitchell PJ; Hill MD; White P; Bracard S; Goyal M;
    Lancet Neurol; 2018 Oct; 17(10):895-904. PubMed ID: 30264728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial.
    Compter A; van der Worp HB; Schonewille WJ; Vos JA; Boiten J; Nederkoorn PJ; Uyttenboogaart M; Lo RT; Algra A; Kappelle LJ;
    Lancet Neurol; 2015 Jun; 14(6):606-14. PubMed ID: 25908089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trial.
    Dávalos A; Cobo E; Molina CA; Chamorro A; de Miquel MA; Román LS; Serena J; López-Cancio E; Ribó M; Millán M; Urra X; Cardona P; Tomasello A; Castaño C; Blasco J; Aja L; Rubiera M; Gomis M; Renú A; Lara B; Martí-Fàbregas J; Jankowitz B; Cerdà N; Jovin TG;
    Lancet Neurol; 2017 May; 16(5):369-376. PubMed ID: 28318984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.